Androgen Excess as a Mechanism for Adipogenic Dysfunction in Polycystic Ovarian Syndrome (PCOS) Women
Women with and Without Polycystic Ovarian Syndrome (PCOS) May Be Eligible to Participate in a Research Study To Learn More About How Body Fat Affects Women’s Health. Dr. Daniel Dumesic and his research team from the UCLA Department of Obstetrics and Gynecology are conducting a study to learn more about endocrine and metabolic conditions in women. The team is recruiting the following three groups of women for participation:
Participants in all groups must meet the following criteria:
If you've answered yes to all of the questions, please email us at Health4Women@ucla.edu or call us at 310-794-2514.
All participants in the study will receive extensive free medical testing including:
After completing the above tests, women with regular menstrual cycles (controls) will conclude their participation in this study. Women with PCOS or irregular menstrual periods will be randomized to take the drug Flutamide or a placebo (sugar pill) every day for 6 consecutive 28 day cycles and then the tests and procedures listed above will be repeated. Flutamide is a drug that temporarily blocks the action of male hormones in women.
Eligible women may receive up to $200 if they are in the control group and $605 if they are in either of the other two groups. Parking vouchers will be provided. UCLA Protocol ID: IRB# 12-001780
Please call (310) 794-2514 to learn more. In order to protect your privacy, please do not include any personal health information if you choose to e-mail us at Health4Women@mednet.ucla.edu.